Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Update on the pharmacotherapy of cerebellar and central vestibular disorders.

Kalla R, Teufel J, Feil K, Muth C, Strupp M.

J Neurol. 2016 Apr;263 Suppl 1:S24-9. doi: 10.1007/s00415-015-7987-x. Epub 2016 Apr 15. Review.

2.

Next-generation sequencing identifies novel CACNA1A gene mutations in episodic ataxia type 2.

Maksemous N, Roy B, Smith RA, Griffiths LR.

Mol Genet Genomic Med. 2016 Jan 20;4(2):211-22. doi: 10.1002/mgg3.196. eCollection 2016 Mar.

3.

Abnormal excitability and episodic low-frequency oscillations in the cerebral cortex of the tottering mouse.

Cramer SW, Popa LS, Carter RE, Chen G, Ebner TJ.

J Neurosci. 2015 Apr 8;35(14):5664-79. doi: 10.1523/JNEUROSCI.3107-14.2015.

4.
5.

Consensus paper: management of degenerative cerebellar disorders.

Ilg W, Bastian AJ, Boesch S, Burciu RG, Celnik P, Claaßen J, Feil K, Kalla R, Miyai I, Nachbauer W, Schöls L, Strupp M, Synofzik M, Teufel J, Timmann D.

Cerebellum. 2014 Apr;13(2):248-68. doi: 10.1007/s12311-013-0531-6.

6.

Genetics of recurrent vertigo and vestibular disorders.

Gazquez I, Lopez-Escamez JA.

Curr Genomics. 2011 Sep;12(6):443-50. doi: 10.2174/138920211797248600.

7.

Use of acetazolamide in sulfonamide-allergic patients with neurologic channelopathies.

Platt D, Griggs RC.

Arch Neurol. 2012 Apr;69(4):527-9. doi: 10.1001/archneurol.2011.2723. Epub 2011 Dec 12.

8.

Large Genomic Deletions in CACNA1A Cause Episodic Ataxia Type 2.

Wan J, Mamsa H, Johnston JL, Spriggs EL, Singer HS, Zee DS, Al-Bayati AR, Baloh RW, Jen JC; CINCH Investigators.

Front Neurol. 2011 Sep 9;2:51. doi: 10.3389/fneur.2011.00051. eCollection 2011.

9.

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.

Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, Freilinger T, Neugebauer H, Spiegel R, Dichgans M, Lehmann-Horn F, Jurkat-Rott K, Brandt T, Jen JC, Jahn K.

Neurology. 2011 Jul 19;77(3):269-75. doi: 10.1212/WNL.0b013e318225ab07. Epub 2011 Jul 6.

10.

Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus.

Strupp M, Thurtell MJ, Shaikh AG, Brandt T, Zee DS, Leigh RJ.

J Neurol. 2011 Jul;258(7):1207-22. doi: 10.1007/s00415-011-5999-8. Epub 2011 Apr 2. Review.

11.

Current treatment of vestibular, ocular motor disorders and nystagmus.

Strupp M, Brandt T.

Ther Adv Neurol Disord. 2009 Jul;2(4):223-39. doi: 10.1177/1756285609103120.

12.

The cerebellum and migraine.

Vincent M, Hadjikhani N.

Headache. 2007 Jun;47(6):820-33. Review.

13.

A gene for episodic ataxia/myokymia maps to chromosome 12p13.

Litt M, Kramer P, Browne D, Gancher S, Brunt ER, Root D, Phromchotikul T, Dubay CJ, Nutt J.

Am J Hum Genet. 1994 Oct;55(4):702-9.

14.

Familial periodic cerebellar ataxia without myokymia maps to a 19-cM region on 19p13.

Teh BT, Silburn P, Lindblad K, Betz R, Boyle R, Schalling M, Larsson C.

Am J Hum Genet. 1995 Jun;56(6):1443-9.

15.

Hereditary myokymia and paroxysmal ataxia linked to chromosome 12 is responsive to acetazolamide.

Lubbers WJ, Brunt ER, Scheffer H, Litt M, Stulp R, Browne DL, van Weerden TW.

J Neurol Neurosurg Psychiatry. 1995 Oct;59(4):400-5.

16.

Persistent superior oblique paresis as a manifestation of familial periodic cerebellar ataxia.

Bain PG, Larkin GB, Calver DM, O'Brien MD.

Br J Ophthalmol. 1991 Oct;75(10):619-21.

17.

Familial dystonic choreoathetosis with myokymia; a sleep responsive disorder.

Byrne E, White O, Cook M.

J Neurol Neurosurg Psychiatry. 1991 Dec;54(12):1090-2.

18.

Familial paroxysmal ataxia: report of a family.

Hawkes CH.

J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):212-3.

Supplemental Content

Support Center